Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $21.10B. Across the group, the median move over the past trading day is −0.50%. Price change over the past year runs from +1.5% to +89.6% across the middle 80 percent of the group, with a median of +53.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| 0J9P.L | Incyte Corporation | $129.02 | +1.10% | +29.30% | +53.49% |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% |
| 0M2N.L | Orion Oyj | 80.10 EUR | −0.50% | +28.64% | +20.48% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.